AAAAAA

   
Results: 1-19 |
Results: 19
PRIMARY PREVENTION OF CORONARY HEART-DISEASE - GUIDANCE FROM FRAMINGHAM - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE AHA TASK-FORCEON RISK REDUCTION
Authors: GRUNDY SM BALADY GJ CRIQUI MH FLETCHER G GREENLAND P HIRATZKA LF HOUSTONMILLER N KRISETHERTON P KRUMHOLZ HM LAROSA J OCKENE IS PEARSON TA REED J WASHINGTON R SMITH SC
Citation: Sm. Grundy et al., PRIMARY PREVENTION OF CORONARY HEART-DISEASE - GUIDANCE FROM FRAMINGHAM - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE AHA TASK-FORCEON RISK REDUCTION, Circulation, 97(18), 1998, pp. 1876-1887
TREATMENT PATTERNS AND DISTRIBUTION OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS IN TREATMENT-ELIGIBLE UNITED-STATES ADULTS
Authors: HOERGER TJ BALA MV BRAY JW WILCOSKY TC LAROSA J
Citation: Tj. Hoerger et al., TREATMENT PATTERNS AND DISTRIBUTION OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS IN TREATMENT-ELIGIBLE UNITED-STATES ADULTS, The American journal of cardiology, 82(1), 1998, pp. 61-65
A NOVEL TECHNIQUE FOR THE SIMULTANEOUS DETERMINATION OF PB-210 AND PO-210 USING A CROWN-ETHER
Authors: VAJDA N LAROSA J ZEISLER R DANESI P KISBENEDEK G
Citation: N. Vajda et al., A NOVEL TECHNIQUE FOR THE SIMULTANEOUS DETERMINATION OF PB-210 AND PO-210 USING A CROWN-ETHER, Journal of environmental radioactivity, 37(3), 1997, pp. 355-372
THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS
Authors: CAMPEAU L KNATTERUD GLMK DOMANSKI M HUNNINGHAKE DB WHITE CW GELLER NL ROSENBERG Y HERD A COCANOUGHER MK DUNN K FARMER J FOREYT J GREGORY K INSULL W JACKSON M KLEIMAN N LEWIS R LLOYD C MARESH K MATTHEW C MINOR S ROBERTS R SALMON A SHACKELFORD P STEWART R THOMPSON M YOUNG J GUINN A HARRIS G HEIBIG J LEVY VV FORRESTER J HICKEY A BUCHBINDER N DAVIDSON R DRURY K EBER L EIGLER N GEFT I GOLDBERG S GRODAN P HENDEL J HIGGINS S HODGSON T HUGHES L KARLSBERG R KATZ J LEPOR N LITVAK F LUPTAK Y MADERA G MARCUS H MONDKAR A NEIDORF B NEUMANN M NIVATPUMIN T RABINOWITZ Y RAYMOND M READER A RURYCZ V SCHAPIRA J SCHLANGER J SILVERBERG R SMITH A TABAK S VALOVIS R GRAY R HOOGWERF B STEWART W BAERVEDT G BOTTSILVERMAN C BREEN C BUCKNER P CABRAL J CRESSMAN M FONSECA C FOSTER J FOSTER R GUTMAN F HARRIS L HEUPLER F HOBBS R HUANG S KALENAK J KASSEM M KOSMORSKY G KRAMER J KURZAWA C LANGSTON R LINCOFF M LINDBERG J LOWDER C MCCAFFERTY F MCKEOWN D MEISLER D MENDLOVIC D MEYERS S MOORE J NOUSEK J RAYMOND R RINCON G ROBIN J ROCKWOOD E SHELDON W SIMPFENDORFER C WALSH H WANESS A WRIGHT K YANAK F GOULET C BEDARD H BOIS M BUJOLD S COTE G DAVIGNON J DEBELDER M DUCHARME AM DOUCET S DUMAS J DYDRA I FOUCHER S CREPEAU J GOSSELIN G GROULX D JOYAL M JUNEAU M LESPERANCE J LEVESQUE C LEVESQUE J MARCIL M OLIVIER M PASTERNAC A POITRAS AM POITRAS D QUEVILLON A RIOUX C ROBITAILLE D SISOUPHONE K SOLYMOSS C HUNNINGHAKE D CHRISTIANSON B DIANGELIS N GARDNER K HELGREN R IACARELLA C KNOBLOCH W LAU L LAXSON D LEON A LONDON E MANION R MCDONALD K MCGINN A MIANULLI M ROBINSON J TURNER G WANG Y WHITE C WILSON R ZIMMER S GOBEL F ANDERSON P BAUMGARD C CHRISTENSEN J FULCO A HANSON K JOHNSON C LARSON B MADISON J MCCORMACK P OSTROV C PECHA R PEDERSON W PIER T RANDALL M RODMAN W ROELLER S SCOTT K SHER N SPEILMAN J THOMPSON R ZUPFER S GOLDENBERG I HEALY B KNATTERUD G TERRIN M CANNER M FICK S FORMAN S HANSON D HOWARD J HUANG AL KARABELAS S LOPRESTI F MERCER W RA K RANDALL A SCHACTMAN M SCHLEIGH B SNIDER R MIRENZI E FISHER M FOX NL CZAJKOWSKI S GELLER N PROBSTFIELD J SHUMAKER S WITTES J YUSUF S ZUCKER D CARTLAND J DAS G MEYER S POWERS T RINGDAL D ROSZA Z SHAHEEN B SIREK M STONE C SNIDER J VANYI J ALAUPOVIC P FESMIRE J WALENGA J BERMES E HOPPENSTEADT D PIFARRE R CARLETON R BAILEY K BRODY B CAIRNS J FURBERG C FUSTER V GRONDIN C JENKINS D LAROSA J MEIER P
Citation: L. Campeau et al., THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS, The New England journal of medicine, 336(3), 1997, pp. 153-162
GUIDE TO PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASES - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE TASK-FORCE ON RISK REDUCTION
Authors: GRUNDY SM BALADY GJ CRIQUI MH FLETCHER G GREENLAND P HIRATZKA LF HOUSTONMILLER N KRISETHERTON P KRUMHOLZ HM LAROSA J OCKENE IS PEARSON TA REED J WASHINGTON R SMITH SC
Citation: Sm. Grundy et al., GUIDE TO PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASES - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE TASK-FORCE ON RISK REDUCTION, Circulation, 95(9), 1997, pp. 2329-2331
WHEN TO START CHOLESTEROL-LOWERING THERAPY IN PATIENTS WITH CORONARY HEART-DISEASE - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE AMERICAN-HEART-ASSOCIATION TASK-FORCE ON RISK REDUCTION
Authors: GRUNDY SM BALADY GJ CRIQUI MH FLETCHER G GREENLAND P HIRATZKA LF HOUSTONMILLER N KRISETHERTON P KRUMHOLZ HM LAROSA J OCKENE IS PEARSON TA REED J SMITH SC WASHINGTON R
Citation: Sm. Grundy et al., WHEN TO START CHOLESTEROL-LOWERING THERAPY IN PATIENTS WITH CORONARY HEART-DISEASE - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE AMERICAN-HEART-ASSOCIATION TASK-FORCE ON RISK REDUCTION, Circulation, 95(6), 1997, pp. 1683-1685
RATIONALE AND DESIGN FOR THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT)
Authors: DAVIS BR CUTLER JA GORDON DJ FURBERG CD WRIGHT JT CUSHMAN WC GRIMM RH LAROSA J WHELTON PK PERRY HM ALDERMAN MH FORD CE OPARIL S FRANCIS C PROSCHAN M PRESSEL S BLACK HR HAWKINS CM
Citation: Br. Davis et al., RATIONALE AND DESIGN FOR THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT), American journal of hypertension, 9(4), 1996, pp. 342-360
CARCINOGENICITY OF LIPID-LOWERING DRUGS
Authors: GRUNDY S BALADY GJ CRIQUI M FLETCHER GF GREENLAND P HIRATZKA L HOUSTONMILLER N KRISETHERTON P KRUMHOLZ H LAROSA J OCKENE IS PEARSON T REED J WASHINGTON RL
Citation: S. Grundy et al., CARCINOGENICITY OF LIPID-LOWERING DRUGS, JAMA, the journal of the American Medical Association, 275(19), 1996, pp. 1481-1481
CHOLESTEROL SCREENING IN ASYMPTOMATIC ADULTS - NO CAUSE TO CHANGE
Authors: GRUNDY S BALADY GJ CRIQUI M FLETCHER G GREENLAND P HIRATZKA L MILLER NH KRISETHERTON P KRUMHOLZ HM LAROSA J OCKENE IS PEARSON T REED J WASHINGTON RL
Citation: S. Grundy et al., CHOLESTEROL SCREENING IN ASYMPTOMATIC ADULTS - NO CAUSE TO CHANGE, Circulation, 93(6), 1996, pp. 1067-1068
EFFICACY AND SAFETY OF A 7-DAY, TRANSDERMAL ESTRADIOL DRUG-DELIVERY SYSTEM - COMPARISON WITH CONJUGATED ESTROGENS AND PLACEBO
Authors: GORDON SF THOMPSON KA RUOFF GE IMIG JR LANE PJ SCHWENKER CE WILSON P WILKINS L FORD C SHARP P SNYDER F COCHRAN J ROSS P KLETZKY O SUH B CABUS E NOTELOWITZ M THOMPSON C BREEN M BAYNE B MCQUARRIE HG BILANZICH S HEINE W KESSLER R STAFL J SOUSTEBY B FIELD CS HERRMANN B ADAMS R MOORE D FRIEDENSEN H FLANDER T MAXYMIV G HARRIS J VAUGHN C SHOUPE D NUNEZ V FERRARO LA FERRARO N JONES CA LEWIS J MINARD W HAYES C PARKER G RANKIN V GRIFFIN R GRUBBS A BABB P HOFF J PATANE J LYNN SC WHITE S PETERSON CM HEISTERMAN J WILKERSON G BULLOCK P GOLDBLATT D BAKER JM MADER N KUK D MERRITT M DAVIES E MERRILL LK SCREWS B PATEL M TUFTS C REYNOLDS C KENNEY R BURTON MC STEVENS C ELLINWOOD LE JOHNSON J NIELSEN JW DWIGHT R ORR JW ORR P CHANG CC BROUGH M MCRAE MA WINTERS M SMUCKER J ELCHINGER M BLOUNT CW CROMARTIE V COLLINS H COLLINS M PROSCH G ROOKIS L SHEVACH A FATIGATI V BRESSMAN P DIAL T COHEN M NANCE V MATILA P WALL E BYRNE B COLBERG C OKO F LAROSA J KENT L MILLER DJ MARTIN K BROWN A DIETIKER F GINSBERG D BREISH B STAUDT M HUNTER R RAU S DONAHUE PA KVAM DC HAWKINSON RW KANNIAINEN CM LAGUS JP CROWLEY JK BURNETT BL KETELSEN R HARRISON LI REYNOLDS SJ ELLMAN H WILTSHIRE JL HEMINGWAY LR
Citation: Sf. Gordon et al., EFFICACY AND SAFETY OF A 7-DAY, TRANSDERMAL ESTRADIOL DRUG-DELIVERY SYSTEM - COMPARISON WITH CONJUGATED ESTROGENS AND PLACEBO, International journal of fertility and menopausal studies, 40(3), 1995, pp. 126-134
PREVENTING HEART-ATTACK AND DEATH IN PATIENTS WITH CORONARY-DISEASE
Authors: SMITH SC BLAIR SN CRIQUI MH FLETCHER GF FUSTER V GERSH BJ GOTTO AM GOULD KL GREENLAND P GRUNDY SM HILL MN HLATKY MA HOUSTONMILLER N KRAUSS RM LAROSA J OCKENE IS OPARIL S PEARSON TA RAPAPORT E STARKE RD
Citation: Sc. Smith et al., PREVENTING HEART-ATTACK AND DEATH IN PATIENTS WITH CORONARY-DISEASE, Journal of the American College of Cardiology, 26(1), 1995, pp. 292-294
EFFECTS OF ESTROGEN OR ESTROGEN PROGESTIN REGIMENS ON HEART-DISEASE RISK-FACTORS IN POSTMENOPAUSAL WOMEN - THE POSTMENOPAUSAL ESTROGEN/PROGESTIN INTERVENTIONS (PEPI) TRIAL/
Authors: MILLER VT LAROSA J BARNABEI V KESSLER C LEVIN G SMITHROTH A GRIFFIN M STOY DB BUSH T ZACUR H FOSTER D ANDERSON J MCKENZIE A MILLER S WOOD PD STEFANICK ML MARCUS R AKANA A HEINRICHS L KIRCHNER C OHANLAN K RUYLE M SHEEHAN M JUDD HL GREENDALE G BAYALOS R LOZANO K KAWAKAMI K BARRETTCONNOR E LANGER R KRITZSILVERSTEIN D CARRIONPETERSEN ML CAVERO C SCHROTT HG JOHNSON SR FEDDERSEN DA KRUTZFELDT DL BENDA JA PAUERSTEIN C TRABAL J SCHENKEN R STERN MP RODRIGUEZSIFUENTES M EASTON C WELLS HB ESPELAND M HOWARD G BYINGTON R LEGAULT C SHUMAKER S HOGAN P HIRE D WASILAUSKAS C JAMES M LANE K TERRELL T REECE S PIERCE J SNOW M ANTHONY S MEBANESIMS IL EINHORN P HUNSBERGER S WACLAWIW M LIPPEL K LUCAS D VERTER J JACKSON S KELAGHAN J PERLMAN J WOLF P MCGOWAN J GORDON S HEYSE S FRADKIN J SHERMAN S PAGE L SORENSON A HULKA B BRODY B BURKMAN R HEANEY R KRAUSS R ROBERTS H WITTES J RIGGS L MOSS R ALBERS J MARCOVINA S FINEBERG SE TRACY RP MERINO M SCULLY R LIVOLSI V KESSLER G
Citation: Vt. Miller et al., EFFECTS OF ESTROGEN OR ESTROGEN PROGESTIN REGIMENS ON HEART-DISEASE RISK-FACTORS IN POSTMENOPAUSAL WOMEN - THE POSTMENOPAUSAL ESTROGEN/PROGESTIN INTERVENTIONS (PEPI) TRIAL/, JAMA, the journal of the American Medical Association, 273(3), 1995, pp. 199-208
PREVENTING HEART-ATTACK AND DEATH IN PATIENTS WITH CORONARY-DISEASE
Authors: SMITH SC BLAIR SN CRIQUI MH FLETCHER GF FUSTER V GERSH BJ GOTTO AM GOULD KL GREENLAND P GRUNDY SM HILL MN HLATKY MA HOUSTONMILLER N KRAUSS RM LAROSA J OCKENE IS OPARIL S PEARSON TA RAPAPORT E STARKE RD
Citation: Sc. Smith et al., PREVENTING HEART-ATTACK AND DEATH IN PATIENTS WITH CORONARY-DISEASE, Circulation, 92(1), 1995, pp. 2-4
SI-29 AND AL-27 MASNMR STUDY OF STRATLINGITE
Authors: KWAN S LAROSA J GRUTZECK MW
Citation: S. Kwan et al., SI-29 AND AL-27 MASNMR STUDY OF STRATLINGITE, Journal of the American Ceramic Society, 78(7), 1995, pp. 1921-1926
DYNAMICS OF THE DOWNWARD FLUX OF PARTICLES AND CARBON IN THE OPEN NORTHWESTERN MEDITERRANEAN-SEA
Authors: MIQUEL JC FOWLER SW LAROSA J BUATMENARD P
Citation: Jc. Miquel et al., DYNAMICS OF THE DOWNWARD FLUX OF PARTICLES AND CARBON IN THE OPEN NORTHWESTERN MEDITERRANEAN-SEA, Deep-sea research. Part 1. Oceanographic research papers, 41(2), 1994, pp. 243-261
ANALYSIS OF ACTINIDES IN THE PRIMARY COOLANT OF A WWER-440 TYPE REACTOR
Authors: VAJDA N LAROSA J PINTER T KEOMLEY G BODIZS D MOLNAR Z
Citation: N. Vajda et al., ANALYSIS OF ACTINIDES IN THE PRIMARY COOLANT OF A WWER-440 TYPE REACTOR, Journal of radioanalytical and nuclear chemistry, 170(2), 1993, pp. 399-409
SR-90 AND PU-239-238 AM-241 IN SOME SAMPLES OF MUSHROOMS AND FOREST SOIL FROM POLAND(240 PU)
Authors: MIETELSKI JW LAROSA J GHODS A
Citation: Jw. Mietelski et al., SR-90 AND PU-239-238 AM-241 IN SOME SAMPLES OF MUSHROOMS AND FOREST SOIL FROM POLAND(240 PU), Journal of radioanalytical and nuclear chemistry, 170(1), 1993, pp. 243-258
VERTICAL PARTICLE FLUXES IN THE LIGURIAN SEA
Authors: MIQUEL JC FOWLER SW LAROSA J
Citation: Jc. Miquel et al., VERTICAL PARTICLE FLUXES IN THE LIGURIAN SEA, Annales de l'Institut oceanographique, 69(1), 1993, pp. 108-110
LOVASTATIN 5-YEAR SAFETY AND EFFICACY STUDY
Authors: DAVIGNON J XHIGNESSE M MAILLOUX H FROHLICH J HAYDEN ML VANETTA H MISHKEL MA MCQUEEN MJ TAN MH WOLFE B NIKKILA E TIKKANEN MJ OJALA JP HELVE E DUJOVNE CA HORNIMAN S GOLDBERG I GINSBERG H GOLDBERG R FARKAS R HUNNINGHAKE D BELL L HELGREN R KNOPP R MCGINNIS B KWITEROVICH P GOLDBERG A BLOOM A MILLER V LAROSA J STOY DB GASPARIS G SCHONFELD G GOLDBERG A ANDERSON C DILLINGHAM M STEINBERG D WITZTUM J KELLY N WEBB H STEIN EA LAMKIN GE LEES RS LEES AM STEIN SW BRENNAN D ILLINGWORTH DR BACON SR GOTTO AM JONES PH FARMER JA PAYTONROSS C FELDMAN EB KUSKE TT DAVIS LC SAMUEL P CHIN B SCHOENFELD BH MARKOWSKI L HAVEL RJ FROST PH TUN P STONE NJ OYER DL RICHARDS L STEIN EA LAZKARZEWSKI P STEINER P TOBERT JA SHAPIRO DR KEEGAN ME GUTWEIN TM PAPPAS F MACHOY B PRAT A GAGNON G DOTY T NYBERG R
Citation: J. Davignon et al., LOVASTATIN 5-YEAR SAFETY AND EFFICACY STUDY, Archives of internal medicine, 153(9), 1993, pp. 1079-1087
Risultati: 1-19 |